Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.40 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.40 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.40 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.39 |
| ▸ | BCL2 | P10415 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorobenzene SCHEMBL1987881 | 0.89 | — | — | |
| Chlorobenzene SCHEMBL10408107 | 0.86 | — | — | |
| Chlorobenzene SCHEMBL3930673 | 0.86 | — | — | |
| Chlorobenzene SCHEMBL1568605 | 0.86 | TSHR (1.00) | TSHRCYP1A2LMNACYP2A6CES2 | |
| Chlorobenzene SCHEMBL1331798 | 0.86 | — | — | |
| SCHEMBL24715429 | 0.86 | TSHR (1.00) | TSHRCYP1A2LMNACYP2A6CES2 | |
| Chlorobenzene SCHEMBL11220629 | 0.86 | TSHR (1.00) | TSHRCYP1A2LMNACYP2A6CES2 | |
| Chlorobenzene SCHEMBL2044 | 0.86 | — | — | |
| Chlorobenzene SCHEMBL2168046 | 0.86 | TSHR (1.00) | TSHRCYP1A2LMNACYP2A6CES2 | |
| Chlorobenzene SCHEMBL1330702 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023135499-A1 | PROCESS FOR ROXADUSTAT USING NOVEL INTERMEDIATES | OPTIMUS DRUGS PVT LTD (IN) | 2023-07-20 | — | — | WO | claimed |
| US-8853439-B2 | Processes for the preparation of lacosamide and intermediates thereof | CADILA HEALTHCARE LIMITED (IN) | 2014-10-07 | — | — | US | claimed |
| EP-2534127-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN Laboratories Limited (IN) | 2012-12-19 | — | — | EP | claimed |
| WO-2011099033-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN LABORATORIES LIMITED (IN) | 2011-08-18 | — | — | WO | claimed |
| CN-100386312-C | Process for synthesizing 2,4-diamino benzene sulfonic acid and its salt | SHANGHAI SHIJING INTERNAT TRAD (CN) | 2008-05-07 | — | — | CN | claimed |
| CN-1900058-A | Process for synthesizing 2,4-diamino benzene sulfonic acid and its salt | SHIJING INTERNAT TRADE CO LTD (CN) | 2007-01-24 | — | — | CN | claimed |
| EP-0388357-B1 | Improved tinted contact lens and method of making the same | CIBA GEIGY AG (CH) | 1993-11-03 | — | — | EP | claimed |
| EP-0388357-A1 | Improved tinted contact lens and method of making the same | CIBA-GEIGY AG (CH) | 1990-09-19 | — | — | EP | claimed |
| CN-119425402-A | Composite filter film of nano cellulose fibril filter material and preparation method and application thereof | 陕西铁路工程职业技术学院 | 2025-02-14 | — | — | CN | disclosed |
| WO-2023157209-A1 | QUANTUM-DOT-CONTAINING COMPOSITION, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, AND METHOD FOR MANUFACTURING QUANTUM-DOT-CONTAINING COMPOSITION | シャープディスプレイテクノロジー株式会社 | 2023-08-24 | — | — | WO | disclosed |
| WO-2023135499-A1 | PROCESS FOR ROXADUSTAT USING NOVEL INTERMEDIATES | OPTIMUS DRUGS PVT LTD (IN) | 2023-07-20 | — | — | WO | disclosed |
| WO-2014205568-A1 | PROCESSES FOR PREPARING AZIDATED COPOLYMERS | LANXESS INC. (CA) | 2014-12-31 | — | — | WO | disclosed |
| US-8907132-B2 | Process for preparing (R)-2-acetamido-N-benzyl-3-methoxy-propionamide | MSN LABORATORIES PRIVATE LIMITED (IN) | 2014-12-09 | — | — | US | disclosed |
| US-20130041180-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN LABORATORIES PRIVATE LIMITED (IN) | 2013-02-14 | — | — | US | disclosed |
| EP-0388357-B1 | Improved tinted contact lens and method of making the same | CIBA GEIGY AG (CH) | 1993-11-03 | — | — | EP | disclosed |
| US-5098445-A | Halotriazine reactive compounds for bonding with polymers for radiation resistance | CIBA-GEIGY CORPORATION (US) | 1992-03-24 | — | — | US | disclosed |
| US-5021068-A | Tinted contact lens and method of manufacture thereof: reactive dye and quaternary phosphonium salt | CIBA-GEIGY CORPORATION (US) | 1991-06-04 | — | — | US | disclosed |
| EP-0388357-A1 | Improved tinted contact lens and method of making the same | CIBA-GEIGY AG (CH) | 1990-09-19 | — | — | EP | disclosed |
| US-4490473-A | Labeled antibodies and methods | PANAB (US) | 1984-12-25 | — | — | US | disclosed |
| US-3982005-A | ANALGESICS | BOEHRINGER INGELHEIM GMBH (DT) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041180-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | AMY1A, PTMA, NAAA | TSHR 1758/4885CYP1A2 9/4885LMNA 570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.